
INCR
Healthcare · Drug Manufacturers - Specialty & Generic · $49.2M market cap
$3.79-0.19 (-4.8%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2023
EPS trend, 90 days to now · 30-day revisions 0 up, 1 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 18, 2025 | Time not confirmed | 0.05 | 0.00 | -100.0% |
| Aug 29, 2025 | Time not confirmed | 0.03 | 0.00 | -100.0% |
| May 1, 2025 | Time not confirmed | 0.01 | -1.58 | -15900.0% |
| Nov 12, 2024 | Time not confirmed | 0.01 | -0.01 | -229.3% |
| Aug 29, 2024 | Time not confirmed | -0.01 | -0.01 | +47.0% |
| May 23, 2024 | Before the open | -0.13 | -0.04 | +72.0% |
| Nov 14, 2023 | Time not confirmed | -0.01 | -0.01 | +21.0% |
| Aug 31, 2023 | After the close | 0.01 | 0.03 | +200.0% |
| May 15, 2023 | After the close | 0.01 | 0.01 | 0.0% |
| Mar 31, 2023 | After the close | 0.05 | 0.05 | +2.7% |
| Nov 15, 2022 | Before the open | 0.08 | 0.04 | -50.0% |
| Aug 15, 2022 | Before the open | 0.08 | 0.09 | +12.5% |
| Apr 4, 2022 | After the close | 0.05 |
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
| -0.03 |
| -160.0% |
| Nov 14, 2021 | After the close | 0.05 | -0.01 | -120.0% |
| Aug 16, 2021 | After the close | 0.04 | 0.03 | -25.0% |
| May 17, 2021 | Before the open | 0.04 | 0.04 | 0.0% |
| Mar 31, 2021 | After the close | — | 0.11 | — |